Skip to main content
Top
Literature
1.
go back to reference McCready VR, O'Sullivan JM. Future directions for unsealed source radionuclide therapy for bone metastases. Eur J Nucl Med 2002; 29:1271–1275. McCready VR, O'Sullivan JM. Future directions for unsealed source radionuclide therapy for bone metastases. Eur J Nucl Med 2002; 29:1271–1275.
2.
go back to reference Bushnell DL, Madsen M, Kahn D, Nathan M, Williams RD. Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents. Nucl Med Commun 1999; 20:875–881.PubMed Bushnell DL, Madsen M, Kahn D, Nathan M, Williams RD. Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents. Nucl Med Commun 1999; 20:875–881.PubMed
Metadata
Title
Enhancement of uptake of therapeutic radiopharmaceuticals in bone lesions
Authors
D. Bushnell
M. Madsen
D. Kahn
Publication date
01-02-2003
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2003
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-002-1086-9

Other articles of this Issue 2/2003

European Journal of Nuclear Medicine and Molecular Imaging 2/2003 Go to the issue